dr.villanueva
TL3 Physician · Manila, PH
Internal medicine. Interested in the comorbidity end — sleep apnoea, hepatic steatosis, renal function.
Joined 14 November 2024 · last posted 4d · groups: clinicians, regional-na
136 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #100 · Outcomes › Progress reports · 24 Jul 2026 · 0 likes On post #96 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #94 · Access › Insurance & coverage · 24 Jul 2026 · 0 likes On post #90 — agreed on the reasoning, with one qualification. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2…
-
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #7 · Sourcing › Red flags · 22 Jul 2026 · 20 likes post #6 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is "100%…
-
Journal club: what we got wrong in an earlier session Replied, post #103 · Evidence › Journal club · 20 Jul 2026 · 3 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #48 · Wellbeing › Sleep · 18 Jul 2026 · 12 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #14 · Analytics › COA interpretation · 16 Jul 2026 · 0 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
NHS criteria and how they are applied in practice Replied, post #28 · Regional › UK & Ireland · 13 Jul 2026 · 3 likes post #27 is right about the mechanism and I think understates the practical bit. Ireland: the Health Products Regulatory Authority implements EU framework.…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #74 · Analytics › Impurities & related substances · 11 Jul 2026 · 5 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Here for the analytics and not much else Replied, post #19 · Lounge › Introductions · 11 Jul 2026 · 0 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
-
What is genuinely unknown about long-term amylin agonism Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Started this topic · Clinical › Comorbidities · 8 Jul 2026 · 4 likes On the subject in the title: Osteoarthritis and mechanical versus metabolic improvement — one year on Working notes rather than a conclusion. General question, not a…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #22 · Sourcing › Vendor reports · 5 Jul 2026 · 9 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
GLP-1 receptor distribution: central and peripheral Replied, post #82 · Pharmacology › Receptor biology · 3 Jul 2026 · 3 likes Worth separating two things that post #78 runs together. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat…
-
Prescription requirements and telehealth models — a second dataset Replied, post #77 · Sourcing › Regulatory · 24 Jun 2026 · 16 likes On post #73 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Micro-titration: a disputed topic, argued properly Replied, post #93 · Practice › Dosing & titration · 22 Jun 2026 · 11 likes Picking up post #90: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #8 · Compounds › Retatrutide · 18 Jun 2026 · 29 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Request: a per-category review queue Replied, post #39 · Meta › Feature requests · 15 Jun 2026 · 3 likes Picking up post #36: that is the part I would want checked first. Use case: explain why you think the feature would help. "I would use this to..." makes the request…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #72 · Devices › Syringes & needles · 14 Jun 2026 · 10 likes On post #68 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
What a certificate commits its issuer to — one year on Replied, post #88 · Analytics › COA interpretation · 14 Jun 2026 · 0 likes Coming back to post #86, because the follow-up matters more than the original answer. Reading old certificates: if a certificate is dated years ago, the lot it…
-
Micronutrient adequacy at low total intake Replied, post #75 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 0 likes post #74 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #99 · Practice › Storage & stability · 8 Jun 2026 · 14 likes I read post #97 twice before replying, because I had assumed the opposite. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #65 · Devices › Syringes & needles · 7 Jun 2026 · 11 likes Coming back to post #63, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
-
Micronutrient adequacy at low total intake Replied, post #22 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 18 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #18 · Pharmacology › Pharmacokinetics · 5 Jun 2026 · 14 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Revisiting: The best-written scientific paper you have read Replied, post #15 · Lounge › Off topic · 4 Jun 2026 · 17 likes I read post #13 twice before replying, because I had assumed the opposite. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of…
-
Injecting into an area that has become firm: why not to Replied, post #11 · Practice › Administration · 3 Jun 2026 · 0 likes post #10 answers the question as asked. The question underneath it is different. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A…
-
Publication patterns in the BPC-157 literature, examined Replied, post #4 · Compounds › Repair & healing peptides · 29 May 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Publication patterns in the BPC-157 literature: a large proportion of the evidence…
-
Reading a trial's population section before its results Replied, post #54 · Evidence › Trials · 26 May 2026 · 12 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Moderation log format change Replied, post #56 · Meta › Announcements · 25 May 2026 · 28 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
[2026 update] Currency conversion and the cost you did not see Replied, post #19 · Sourcing › Payments · 20 May 2026 · 9 likes Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for cancellation is important before the first charge.
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #10 · Practice › Dosing & titration · 14 May 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #45 · Evidence › Journal club · 13 May 2026 · 4 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #26 · Analytics › Home & field testing · 11 May 2026 · 1 like This follows post #23 rather than contradicting it. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work.…
-
Coming back to: Time to steady state after a dose increase Replied, post #47 · Pharmacology › Pharmacokinetics · 6 May 2026 · 0 likes Worth separating two things that post #43 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A parcel stationary at a customs facility for nine days Replied, post #56 · Sourcing › Logistics · 6 May 2026 · 24 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Why the timeline is on the right and not the left — what changed since Replied, post #30 · Meta › Site feedback · 3 May 2026 · 15 likes post #29 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #64 · Evidence › Trials · 28 Apr 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #10 · Evidence › Journal club · 28 Apr 2026 · 2 likes Coming back to post #8, because the follow-up matters more than the original answer. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #39 · Evidence › Preprints · 26 Apr 2026 · 20 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Forced degradation studies: designing one that is informative Replied, post #44 · Analytics › Method validation · 26 Apr 2026 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal…
-
Historical amylin analogues and what happened to them Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 26 Apr 2026 · 0 likes This follows post #2 rather than contradicting it. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #25 · Practice › Reconstitution · 25 Apr 2026 · 3 likes On post #21 — agreed on the reasoning, with one qualification. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
-
List price versus negotiated price versus what you pay Replied, post #82 · Access › Pricing · 15 Apr 2026 · 11 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
List price versus negotiated price versus what you pay Replied, post #61 · Access › Pricing · 13 Apr 2026 · 2 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Grapefruit: why this class is not the class that cares Replied, post #104 · Practice › Interactions · 1 Apr 2026 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: is percentage weight change the right endpoint? Replied, post #13 · Evidence › Journal club · 25 Mar 2026 · 18 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #61 · Practice › Storage & stability · 11 Mar 2026 · 6 likes post #60 is right about the mechanism and I think understates the practical bit. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure…
-
Second pass at: Identical chromatograms across two different lots Replied, post #55 · Sourcing › Red flags · 10 Mar 2026 · 7 likes Coming back to post #53, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #107 · Access › Pricing · 5 Mar 2026 · 10 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #39 · Practice › Interactions · 4 Mar 2026 · 20 likes On post #35 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 28 Feb 2026 · 1 like For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #51 · Analytics › Method validation · 24 Feb 2026 · 11 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #42 · Analytics › Mass spectrometry · 19 Feb 2026 · 0 likes I read post #40 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #33 · Analytics › Mass spectrometry · 10 Feb 2026 · 1 like Resolution: "high resolution" commonly means
-
Trifluoroacetate content and its consequences Replied, post #88 · Analytics › Impurities & related substances · 5 Feb 2026 · 7 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Angle of injection and whether 90 degrees is always right Replied, post #90 · Practice › Administration · 28 Jan 2026 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The headache that turns out to be dehydration Replied, post #123 · Nutrition & Training › Hydration & electrolytes · 4 Jan 2026 · 12 likes post #122 answers the question as asked. The question underneath it is different. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #33 · Outcomes › Body composition · 30 Dec 2025 · 15 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Citation sweep results: how many references did not say what was claimed Replied, post #23 · Meta › Wiki maintenance · 28 Dec 2025 · 7 likes Picking up post #20: that is the part I would want checked first. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned.…
-
DXA precision and the least significant change for lean mass Replied, post #82 · Outcomes › Body composition · 18 Dec 2025 · 24 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #90 · Compounds › Oral incretins · 14 Dec 2025 · 0 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Citation sweep results: how many references did not say what was claimed Replied, post #12 · Meta › Wiki maintenance · 1 Dec 2025 · 12 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Tracking that stops updating and then resumes Replied, post #51 · Sourcing › Logistics · 30 Nov 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading SURMOUNT-1 without the press release Replied, post #73 · Compounds › Tirzepatide · 21 Nov 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #52 · Wellbeing › Mental health · 19 Nov 2025 · 1 like Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Availability by country, dated, with primary sources Replied, post #63 · Access › International · 17 Nov 2025 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Started this topic · Practice › Storage & stability · 14 Nov 2025 · 6 likes Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common figures Writing it up because I had to work it out twice and would rather nobody…
-
The headache that turns out to be dehydration Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 27 Oct 2025 · 29 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
A comparison of home results against a laboratory result on the same vial Replied, post #52 · Analytics › Home & field testing · 21 Oct 2025 · 13 likes This follows post #49 rather than contradicting it. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone),…
-
A 40-week log with the measurement method stated Replied, post #34 · Outcomes › Progress reports · 19 Oct 2025 · 0 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Substitution between formats during a shortage Replied, post #77 · Access › Shortages · 17 Oct 2025 · 4 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #2 · Practice › Administration · 17 Oct 2025 · 0 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Second pass at: Programming during a large energy deficit Replied, post #38 · Nutrition & Training › Resistance training · 13 Oct 2025 · 18 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #72 · Sourcing › Vendor reports · 13 Oct 2025 · 32 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #66 · Start Here › How to Ask · 8 Oct 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #47 · Evidence › Preprints · 29 Sep 2025 · 28 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Titles that describe the question, not the situation Replied, post #98 · Start Here › How to Ask · 17 Sep 2025 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #60 · Data & Tools › Datasets · 8 Sep 2025 · 0 likes Coming back to post #58, because the follow-up matters more than the original answer. How to contribute: if you have longitudinal data you want to add, the format is…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #74 · Compounds › Retatrutide · 1 Sep 2025 · 12 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
A preprint whose numbers changed substantially at publication Replied, post #36 · Evidence › Preprints · 31 Aug 2025 · 0 likes Worth separating two things that post #32 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #120 · Wellbeing › Mental health · 28 Aug 2025 · 5 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Persistent vomiting and the threshold for seeking help Replied, post #21 · Safety › Adverse events · 20 Aug 2025 · 0 likes post #20 answers the question as asked. The question underneath it is different. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #27 · Analytics › HPLC & UHPLC · 5 Aug 2025 · 5 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
A ten-fold dose error caught before injection — one year on Replied, post #143 · Devices › Syringes & needles · 5 Aug 2025 · 0 likes On post #139 — agreed on the reasoning, with one qualification. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the…
-
What a 2 ppm match establishes, and what it does not Replied, post #39 · Analytics › Mass spectrometry · 5 Aug 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to research a compound with no human data without deceiving yourself Replied, post #54 · Compounds › Other compounds · 1 Aug 2025 · 6 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #13 · Practice › Side effects · 1 Aug 2025 · 7 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #26 · Compounds › Secretagogues & GH axis · 1 Aug 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #94 · Wellbeing › Mental health · 21 Jul 2025 · 0 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
A supplier that answers analytical questions with restated claims Replied, post #117 · Sourcing › Red flags · 13 Jul 2025 · 0 likes This follows post #114 rather than contradicting it. Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or…
-
Sequence verification for an obscure compound: how it is done Replied, post #86 · Compounds › Other compounds · 8 Jul 2025 · 0 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #73 · Compounds › Tirzepatide · 18 Jun 2025 · 25 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Pre-registering a personal experiment, seriously Replied, post #51 · Research Methods › N-of-1 designs · 30 May 2025 · 22 likes Picking up post #48: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
A report I filed that turned out to be wrong, and the correction Replied, post #69 · Sourcing › Vendor reports · 25 May 2025 · 7 likes Worth separating two things that post #65 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #116 · Sourcing › Independent verification · 18 May 2025 · 3 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Dizziness on standing: the ordinary explanation first Replied, post #25 · Nutrition & Training › Hydration & electrolytes · 29 Apr 2025 · 8 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Adjudicated events and why the definition matters — the long version Replied, post #123 · Evidence › Trials · 28 Apr 2025 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Reading a trial's population section before its results — does this still hold? Replied, post #28 · Evidence › Trials · 21 Apr 2025 · 22 likes This follows post #25 rather than contradicting it. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least…
-
Asking about a compound your prescriber has not heard of Replied, post #21 · Clinical › Prescriber conversations · 20 Apr 2025 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Reading a trial's population section before its results — does this still hold? Replied, post #11 · Evidence › Trials · 15 Apr 2025 · 10 likes post #10 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #105 · Documentation › Doc review · 14 Apr 2025 · 1 like post #104 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #25 · Regional › UK & Ireland · 25 Mar 2025 · 2 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Started this topic · Compounds › Tirzepatide · 23 Mar 2025 · 19 likes Posting this under the heading it deserves: Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Everything below is what sits behind that. I have seen SCALE (…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #15 · Evidence › Trials · 20 Mar 2025 · 21 likes Picking up post #12: that is the part I would want checked first. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm…
-
Checking someone else's arithmetic: a worked example thread Replied, post #30 · Practice › Reconstitution · 17 Mar 2025 · 29 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Validating a method you did not develop — does this still hold? Replied, post #95 · Analytics › Method validation · 10 Mar 2025 · 0 likes post #94 is right about the mechanism and I think understates the practical bit. Why two laboratories may disagree: after validating the same method, they may still…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #83 · Access › International · 7 Mar 2025 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Validating a method you did not develop — does this still hold? Replied, post #76 · Analytics › Method validation · 5 Mar 2025 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #10 · Access › Pricing · 1 Mar 2025 · 0 likes This follows post #7 rather than contradicting it. Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #39 · Practice › Reconstitution · 23 Feb 2025 · 28 likes Coming back to post #37, because the follow-up matters more than the original answer. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) =…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #13 · Practice › Reconstitution · 19 Feb 2025 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #69 · Evidence › Meta-analyses · 7 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #10 · Compounds › Tirzepatide · 4 Feb 2025 · 0 likes This follows post #7 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Criticising the method without criticising the authors Replied, post #35 · Evidence › Study critique · 28 Jan 2025 · 4 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Telehealth prescribing models in the US Replied, post #46 · Regional › North America · 16 Jan 2025 · 6 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Building a sensible monitoring schedule with your prescriber Replied, post #77 · Clinical › Bloodwork · 21 Dec 2024 · 2 likes Picking up post #74: that is the part I would want checked first. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free…
-
Building a sensible monitoring schedule with your prescriber Replied, post #68 · Clinical › Bloodwork · 21 Dec 2024 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Gallbladder disease risk with rapid weight loss Replied, post #41 · Clinical › Comorbidities · 9 Dec 2024 · 0 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Gallbladder disease risk with rapid weight loss Replied, post #38 · Clinical › Comorbidities · 2 Dec 2024 · 31 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Asking about a compound your prescriber has not heard of — one year on Replied, post #8 · Clinical › Prescriber conversations · 25 Nov 2024 · 28 likes On post #4 — agreed on the reasoning, with one qualification. Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes,…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #58 · Compounds › Tirzepatide · 17 Nov 2024 · 24 likes On post #54 — agreed on the reasoning, with one qualification. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #13 · Evidence › Journal club · 12 Nov 2024 · 4 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Time to steady state after a dose increase Replied, post #154 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Request: a diff view for wiki revisions Replied, post #19 · Meta › Feature requests · 24 Oct 2024 · 11 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #21 · Practice › Interactions · 22 Oct 2024 · 23 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #72 · Clinical › Comorbidities · 21 Oct 2024 · 9 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #37 · Access › Shortages · 10 Oct 2024 · 1 like Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Irish differences from the UK position Replied, post #21 · Regional › UK & Ireland · 4 Oct 2024 · 16 likes Picking up post #18: that is the part I would want checked first. Cross-border arrangements: some people source from other EU countries. Rules on import for personal…
-
Pen mechanics when the cartridge is nearly empty Replied, post #3 · Devices › Pens & autoinjectors · 21 Sep 2024 · 0 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Progressive overload when the scale is falling — one year on Replied, post #54 · Nutrition & Training › Resistance training · 14 Sep 2024 · 0 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Reporting a discrepancy without making an allegation Replied, post #58 · Sourcing › Vendor reports · 5 Sep 2024 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #111 · Research Methods › Statistics · 24 Aug 2024 · 12 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Pen wastage and its effect on real cost Replied, post #15 · Access › Pricing · 12 Aug 2024 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #65 · Evidence › Journal club · 25 Jul 2024 · 24 likes This follows post #62 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
How this community labels and discusses unrefereed work Replied, post #103 · Evidence › Preprints · 22 Jul 2024 · 0 likes I read post #101 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Cold packs, phase-change material, and what survives ten days Replied, post #40 · Sourcing › Logistics · 24 Jun 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…